Dumlu, R. Et Al. 2022. Investigation of ceftazidime-avibactam susceptibility in clinical isolates of gram-negative bacteria. Turkish Journal of Medical Sciences , vol.52, no.6 , 1839-1844.

Dumlu, R., YURTTUTAN UYAR, N., Ayaş, M., Aksoy, N., Öztürk, N., & KOCAGÖZ, A. S., (2022). Investigation of ceftazidime-avibactam susceptibility in clinical isolates of gram-negative bacteria. Turkish Journal of Medical Sciences , vol.52, no.6, 1839-1844.

Dumlu, Rıdvan Et Al. "Investigation of ceftazidime-avibactam susceptibility in clinical isolates of gram-negative bacteria," Turkish Journal of Medical Sciences , vol.52, no.6, 1839-1844, 2022

Dumlu, Rıdvan Et Al. "Investigation of ceftazidime-avibactam susceptibility in clinical isolates of gram-negative bacteria." Turkish Journal of Medical Sciences , vol.52, no.6, pp.1839-1844, 2022

Dumlu, R. Et Al. (2022) . "Investigation of ceftazidime-avibactam susceptibility in clinical isolates of gram-negative bacteria." Turkish Journal of Medical Sciences , vol.52, no.6, pp.1839-1844.

@article{article, author={Rıdvan Dumlu Et Al. }, title={Investigation of ceftazidime-avibactam susceptibility in clinical isolates of gram-negative bacteria}, journal={Turkish Journal of Medical Sciences}, year=2022, pages={1839-1844} }